glp-1 in canada 3 million Canadians use drugs. Survey says that's changing their appetites — and habits glp-1 in canada Drug Coverage

Heres how they fit into a comprehensive approach to lasting weight loss: Jumpstarting Weight Loss: GLP-1 therapies help reduce appetite, increase feelings of fullness, and promote fat loss, making it easier for individuals to kickstart their weight loss journey, especially if diet and exercise alone have not been successful

Medications such as semaglutide (Wegovy) and liraglutide (Saxenda) are licensed for weight management, while other GLP-1 receptor agonists like dulaglutide (Trulicity) are licensed only for type 2 diabetes in the UK

The GLP-1 space is evolving rapidly, and the platforms that evolve with itby aligning with pharma, regulators, and patient expectationsare the ones that will thrive

Not at lower doses